Arbutus Biopharma Corp (NASDAQ: ABUS) is -6.42% lower on its value in year-to-date trading and has touched a low of $2.63 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABUS stock was last observed hovering at around $3.16 in the last trading session, with the day’s loss setting it -0.1%.
Currently trading at $3.06, the stock is -6.57% and -7.75% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing -3.16% at the moment leaves the stock -14.94% off its SMA200. ABUS registered 3.03% gain for a year compared to 6-month loss of -20.73%. The firm has a 50-day simple moving average (SMA 50) of $3.3172 and a 200-day simple moving average (SMA200) of $3.5977.
The stock witnessed a -4.38% gain in the last 1 month and extending the period to 3 months gives it a -6.71%, and is -3.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.28% over the week and 6.20% over the month.
Arbutus Biopharma Corp (ABUS) has around 44 employees, a market worth around $585.93M and $6.17M in sales. Profit margin for the company is -1133.04%. Distance from 52-week low is 16.35% and -35.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-67.88%).
The EPS is expected to grow by 43.68% this year
201.0 institutions hold shares in Arbutus Biopharma Corp (ABUS), with institutional investors hold 70.48% of the company’s shares. The shares outstanding are 189.96M, and float is at 148.63M with Short Float at 6.63%. Institutions hold 54.95% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 20.96 million shares valued at $64.77 million. The investor’s holdings represent 11.1466 of the ABUS Shares outstanding. As of 2024-06-30, the second largest holder is WHITEFORT CAPITAL MANAGEMENT, LP with 12.87 million shares valued at $39.76 million to account for 6.8432 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 11.55 million shares representing 6.1434 and valued at over $35.7 million, while TWO SEAS CAPITAL LP holds 4.5584 of the shares totaling 8.57 million with a market value of $26.49 million.
Arbutus Biopharma Corp (ABUS) Insider Activity
Still, SEC filings show that on Mar 24 ’25, Sofia Michael J. (Officer) Proposed Sale 250,000 shares at an average price of $3.28 for $0.82 million. The insider now directly holds shares of Arbutus Biopharma Corp (ABUS).
